What is Patient21 SE?
Patient21 SE operates at the intersection of clinical excellence and digital infrastructure. By prioritizing the doctor-patient relationship, the company addresses systemic inefficiencies in healthcare delivery, such as siloed data and outdated administrative processes. Through a robust network of experts and a data-driven platform, Patient21 SE facilitates personalized treatment plans and holistic health management. The company's market position is defined by its commitment to removing operational obstacles, thereby empowering medical professionals to focus on patient outcomes rather than bureaucratic hurdles.
How much funding has Patient21 SE raised?
Patient21 SE has raised a total of $108M across 1 funding round:
Series C
$108M
Series C (2023): $108M with participation from Target Global, The Artian, IPF Partners, and Pitango
Key Investors in Patient21 SE
Target Global
A leading pan-European technology investment firm with over 3 billion in assets under management, specializing in supporting companies from pre-seed to pre-IPO stages.
IPF Partners
A specialized alternative financing provider focused on the healthcare sector, offering tailored debt and equity solutions for digital health, biopharma, and medtech companies.
The Artian
A Creative Leadership Development Atelier that assists organizations in nurturing creative leaders and fostering innovation through their unique Business Artistry philosophy.
What's next for Patient21 SE?
With this significant capital infusion, Patient21 SE is well-positioned to accelerate its expansion strategy and deepen its technological integration across European markets. The company is expected to leverage these funds to scale its network of clinics and enhance its proprietary data platform, which serves as the backbone for its personalized care model. As the firm transitions from its current growth phase toward broader enterprise-level adoption, the focus will likely shift toward optimizing cross-specialty collaboration and achieving greater interoperability within the healthcare ecosystem. This strategic trajectory aims to solidify Patient21 SE as a cornerstone of modern, patient-centric medical delivery.
See full Patient21 SE company page
